Not a good buy right now for an impatient trader: short-term pattern stats skew slightly negative (next day expected drift ~-2.42%) and price is still below the key pivot (29.051).
Medium-term backdrop is constructive (bullish moving averages + strong analyst support), but the best risk/reward is likely on a pullback closer to support (27.817).
Activity: Today’s option volume is elevated vs 30D average (35.62x), suggesting heightened speculation/attention.
Volatility: IV30 ~76.9 with IV percentile 93.6 (very high) vs historical vol 64.5 — options are pricing big moves; this often coincides with event risk or crowded positioning.
Takeaway: Options market leans bullish, but the very high IV implies expectations are already rich (less attractive to initiate fresh long exposure purely on sentiment).
Technical Summary
Sell
3
Buy
11
Positive Catalysts
scheduled 2026-02-27 pre-market (could re-rate the stock if results/guide beat).
Neutral/Negative Catalysts
Insider selling: Insiders are selling, with selling amount up ~2514% over the last month (material negative sentiment signal).
Near-term technical setup: Price below pivot with fading MACD momentum; statistical pattern bias points to mild near-term downside.
Options pricing: IV percentile ~93.6 indicates the market is already pricing large moves; can precede volatility and makes “buy now” entries less forgiving.
Institutional flow: Hedge funds neutral (no strong accumulation signal).
Overall: Growth and profitability trends are clearly improving, supporting a medium-term bullish thesis.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Trend: Ratings have been consistently positive with several price target increases into late 2025, plus a fresh Buy initiation in early 2026.
Recent actions:
Roth Capital (2026-01-07): Initiated Buy, PT $31.
Mizuho (2025-12-12): Outperform, PT raised to $36 from $33.
Jefferies (2025-11-15): Buy, PT raised to $32 from $28.
Barclays (2025-11-13): Overweight, PT $32.
KeyBanc (2025-11-11): Overweight, PT raised to $30 from $25.
Susquehanna (2025-11-11): Positive, PT raised to $33 from $32.
Wall Street pros: Execution momentum, diversified cash flows via power, and CCUS/power optionality.
Wall Street cons: Sector sentiment can be pressured by gas/oil macro (oversupply/storage commentary), and the bull case depends on continued execution and catalysts (e.g., power-related upside).
Wall Street analysts forecast BKV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BKV is 31.43 USD with a low forecast of 26 USD and a high forecast of 36 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Analyst Rating
Wall Street analysts forecast BKV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BKV is 31.43 USD with a low forecast of 26 USD and a high forecast of 36 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Buy
0 Hold
0 Sell
Strong Buy
Current: 28.820
Low
26
Averages
31.43
High
36
Current: 28.820
Low
26
Averages
31.43
High
36
Roth Capital
Leo Mariani
Buy
maintain
$31 -> $32
AI Analysis
2026-02-05
New
Reason
Roth Capital
Leo Mariani
Price Target
$31 -> $32
AI Analysis
2026-02-05
New
maintain
Buy
Reason
Roth Capital analyst Leo Mariani raised the firm's price target on BKV Corp. to $32 from $31 and keeps a Buy rating on the shares. The firm expects the company to report a solid Q4 report with production toward the higher end of the guided range. Roth cites its confidence in the earnings report for the target boost.
KeyBanc
Overweight
maintain
$30 -> $34
2026-02-05
New
Reason
KeyBanc
Price Target
$30 -> $34
2026-02-05
New
maintain
Overweight
Reason
KeyBanc raised the firm's price target on BKV Corp. to $34 from $30 and keeps an Overweight rating on the shares. After an earlier than expected close of the Power WI acquisition, the firm fine-tunes modeling forecasts ahead of Q4 2025 earnings. KeyBanc remains constructive on BKV shares, given expectations on an agreement with a hyperscaler this year, as well as strong execution across all three segments.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BKV
